BridgeBio Pharma, Inc. ($BBIO)
Valantine Hannah โ Director
Shares
14,584
Price
$67.08
Total Value
$978,284.51
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Valantine Hannah |
|---|---|
| Title | Director |
| Transaction Date | Feb 27, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 14,584 |
| Price per Share | $67.08 |
| Total Value | $978,284.51 |
| Shares Owned After | 18,365 |
| Derivative | No |
| Accession Number | 0001470831-26-000236 |
| Document | View SEC Filing |